Addition of SNS-301 to Checkpoint Inhibitor Treatment in Metastatic/Recurrent SCCHN

NCT04034225 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

25

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated by the sponsor

Conditions

Squamous Cell Carcinoma of the Head and Neck

Interventions

DRUG: SNS-301
DRUG: Pembrolizumab

Sponsor

Sensei Biotherapeutics, Inc.